Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Antisense Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antisense Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense Therapy Overall Market Size
2.1 Global Antisense Therapy Market Size: 2021 VS 2028
2.2 Global Antisense Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense Therapy Players in Global Market
3.2 Top Global Antisense Therapy Companies Ranked by Revenue
3.3 Global Antisense Therapy Revenue by Companies
3.4 Top 3 and Top 5 Antisense Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antisense Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense Therapy Players in Global Market
3.6.1 List of Global Tier 1 Antisense Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Antisense Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Antisense Therapy Market Size Markets, 2021 & 2028
4.1.2 RNA Antisense Therapy
4.1.3 DNA Antisense Therapy
4.2 By Type - Global Antisense Therapy Revenue & Forecasts
4.2.1 By Type - Global Antisense Therapy Revenue, 2017-2022
4.2.2 By Type - Global Antisense Therapy Revenue, 2023-2028
4.2.3 By Type - Global Antisense Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antisense Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Other
5.2 By Application - Global Antisense Therapy Revenue & Forecasts
5.2.1 By Application - Global Antisense Therapy Revenue, 2017-2022
5.2.2 By Application - Global Antisense Therapy Revenue, 2023-2028
5.2.3 By Application - Global Antisense Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Antisense Therapy Market Size, 2021 & 2028
6.2 By Region - Global Antisense Therapy Revenue & Forecasts
6.2.1 By Region - Global Antisense Therapy Revenue, 2017-2022
6.2.2 By Region - Global Antisense Therapy Revenue, 2023-2028
6.2.3 By Region - Global Antisense Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Antisense Therapy Revenue, 2017-2028
6.3.2 US Antisense Therapy Market Size, 2017-2028
6.3.3 Canada Antisense Therapy Market Size, 2017-2028
6.3.4 Mexico Antisense Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Antisense Therapy Revenue, 2017-2028
6.4.2 Germany Antisense Therapy Market Size, 2017-2028
6.4.3 France Antisense Therapy Market Size, 2017-2028
6.4.4 U.K. Antisense Therapy Market Size, 2017-2028
6.4.5 Italy Antisense Therapy Market Size, 2017-2028
6.4.6 Russia Antisense Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Antisense Therapy Market Size, 2017-2028
6.4.8 Benelux Antisense Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Antisense Therapy Revenue, 2017-2028
6.5.2 China Antisense Therapy Market Size, 2017-2028
6.5.3 Japan Antisense Therapy Market Size, 2017-2028
6.5.4 South Korea Antisense Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Antisense Therapy Market Size, 2017-2028
6.5.6 India Antisense Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Antisense Therapy Revenue, 2017-2028
6.6.2 Brazil Antisense Therapy Market Size, 2017-2028
6.6.3 Argentina Antisense Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antisense Therapy Revenue, 2017-2028
6.7.2 Turkey Antisense Therapy Market Size, 2017-2028
6.7.3 Israel Antisense Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Antisense Therapy Market Size, 2017-2028
6.7.5 UAE Antisense Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals Antisense Therapy Major Product Offerings
7.1.4 Alnylam Pharmaceuticals Antisense Therapy Revenue in Global Market (2017-2022)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Ionis Pharmaceuticals, Inc.
7.2.1 Ionis Pharmaceuticals, Inc. Corporate Summary
7.2.2 Ionis Pharmaceuticals, Inc. Business Overview
7.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Major Product Offerings
7.2.4 Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue in Global Market (2017-2022)
7.2.5 Ionis Pharmaceuticals, Inc. Key News
7.3 Arbutus Biopharma (Tekmira)
7.3.1 Arbutus Biopharma (Tekmira) Corporate Summary
7.3.2 Arbutus Biopharma (Tekmira) Business Overview
7.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Major Product Offerings
7.3.4 Arbutus Biopharma (Tekmira) Antisense Therapy Revenue in Global Market (2017-2022)
7.3.5 Arbutus Biopharma (Tekmira) Key News
7.4 Isarna Therapeutics
7.4.1 Isarna Therapeutics Corporate Summary
7.4.2 Isarna Therapeutics Business Overview
7.4.3 Isarna Therapeutics Antisense Therapy Major Product Offerings
7.4.4 Isarna Therapeutics Antisense Therapy Revenue in Global Market (2017-2022)
7.4.5 Isarna Therapeutics Key News
7.5 Arrowhead
7.5.1 Arrowhead Corporate Summary
7.5.2 Arrowhead Business Overview
7.5.3 Arrowhead Antisense Therapy Major Product Offerings
7.5.4 Arrowhead Antisense Therapy Revenue in Global Market (2017-2022)
7.5.5 Arrowhead Key News
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Corporate Summary
7.6.2 Dicerna Pharmaceuticals Business Overview
7.6.3 Dicerna Pharmaceuticals Antisense Therapy Major Product Offerings
7.6.4 Dicerna Pharmaceuticals Antisense Therapy Revenue in Global Market (2017-2022)
7.6.5 Dicerna Pharmaceuticals Key News
7.7 Quark Pharmaceuticals
7.7.1 Quark Pharmaceuticals Corporate Summary
7.7.2 Quark Pharmaceuticals Business Overview
7.7.3 Quark Pharmaceuticals Antisense Therapy Major Product Offerings
7.7.4 Quark Pharmaceuticals Antisense Therapy Revenue in Global Market (2017-2022)
7.7.5 Quark Pharmaceuticals Key News
7.8 Benitec Biopharma
7.8.1 Benitec Biopharma Corporate Summary
7.8.2 Benitec Biopharma Business Overview
7.8.3 Benitec Biopharma Antisense Therapy Major Product Offerings
7.8.4 Benitec Biopharma Antisense Therapy Revenue in Global Market (2017-2022)
7.8.5 Benitec Biopharma Key News
7.9 Sylentis
7.9.1 Sylentis Corporate Summary
7.9.2 Sylentis Business Overview
7.9.3 Sylentis Antisense Therapy Major Product Offerings
7.9.4 Sylentis Antisense Therapy Revenue in Global Market (2017-2022)
7.9.5 Sylentis Key News
7.10 Gradalis
7.10.1 Gradalis Corporate Summary
7.10.2 Gradalis Business Overview
7.10.3 Gradalis Antisense Therapy Major Product Offerings
7.10.4 Gradalis Antisense Therapy Revenue in Global Market (2017-2022)
7.10.5 Gradalis Key News
7.11 Sarepta Therapeutics
7.11.1 Sarepta Therapeutics Corporate Summary
7.11.2 Sarepta Therapeutics Business Overview
7.11.3 Sarepta Therapeutics Antisense Therapy Major Product Offerings
7.11.4 Sarepta Therapeutics Antisense Therapy Revenue in Global Market (2017-2022)
7.11.5 Sarepta Therapeutics Key News
7.12 Biogen
7.12.1 Biogen Corporate Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Antisense Therapy Major Product Offerings
7.12.4 Biogen Antisense Therapy Revenue in Global Market (2017-2022)
7.12.5 Biogen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer